Cargando…
Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor
Breast cancer is one of the most frequently diagnosed cancers. Although biomarkers are continuously being discovered, few specific markers, rather than classification markers, representing the aggressiveness and invasiveness of breast cancer are known. In this study, we used samples from canine mamm...
Autores principales: | Park, Hyoung-Min, Kim, HuiSu, Kim, Dong Wook, Yoon, Jong-Hyuk, Kim, Byung-Gyu, Cho, Je-Yoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781914/ https://www.ncbi.nlm.nih.gov/pubmed/33298249 http://dx.doi.org/10.5483/BMBRep.2020.53.12.238 |
Ejemplares similares
-
Exploring the key communicator role of exosomes in cancer microenvironment through proteomics
por: Kim, HuiSu, et al.
Publicado: (2019) -
The landscape of PBMC methylome in canine mammary tumors reveals the epigenetic regulation of immune marker genes and its potential application in predicting tumor malignancy
por: Nam, A-Reum, et al.
Publicado: (2023) -
Transcriptome Signatures of Canine Mammary Gland Tumors and Its Comparison to Human Breast Cancers
por: Lee, Kang-Hoon, et al.
Publicado: (2018) -
ANK2 Hypermethylation in Canine Mammary Tumors and Human Breast Cancer
por: Schabort, Johannes J., et al.
Publicado: (2020) -
Lipid Profile Rather Than the LCAT Mutation Explains Renal Disease in Familial LCAT Deficiency
por: Lamiquiz-Moneo, Itziar, et al.
Publicado: (2019)